Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling
MicroRNA-29 is known to reduce collagen production in fibroblasts thereby inhibiting fibrosis in various organs. Here, Sassi et al. show that miR-29 can also enhance fibrotic signalling and pathological hypertrophy of the heart through its action in cardiomyocytes.
Main Authors: | Yassine Sassi, Petros Avramopoulos, Deepak Ramanujam, Laurenz Grüter, Stanislas Werfel, Simon Giosele, Andreas-David Brunner, Dena Esfandyari, Aikaterini S. Papadopoulou, Bart De Strooper, Norbert Hübner, Regalla Kumarswamy, Thomas Thum, Xiaoke Yin, Manuel Mayr, Bernhard Laggerbauer, Stefan Engelhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-01737-4 |
Similar Items
-
MicroRNAs as therapeutic targets in cardiovascular disease
by: Bernhard Laggerbauer, et al.
Published: (2022-06-01) -
Transcriptional changes during isoproterenol-induced cardiac fibrosis in mice
by: Disha Nanda, et al.
Published: (2023-12-01) -
SMOOTH MYOCYTES AND CARDIOVASCULAR DISEASE
by: S. S. Todorov
Published: (2009-10-01) -
Effects of occlusal disharmony on cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage in mice.
by: Yuka Yagisawa, et al.
Published: (2020-01-01) -
Acidosis in models of cardiac ventricular myocytes
by: Crampin, E, et al.
Published: (2006)